GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Clearmind Medicine CMND · USD

Health Care · US listing · 🇺🇸 United States

Compare

5.50

-1.43%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Clearmind Medicine

Its shares trade under the ticker CMND. It has been listed since 15 May 2018.

Clearmind Medicine Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-15. Clearmind Medicine Inc. is a Canada-based psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company’s intellectual portfolio consists of fourteen patent families. The firm's portfolio consists of patent families, such as alcoholic beverage substitute and binge behavior regulators.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
15 May 2018
Head office
101-1220 WEST 6TH AVENUE, VANCOUVER, BRITISH COLUMBIA, Z4, V6H1A5
Incorporated in
Z4
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Amitay WeissIndependent Chairman of the Board
  • Dr. Adi Zuloff-ShaniChief Executive Officer
  • Mr. Alan RootenbergChief Financial Officer
  • Prof. Mark HadenVice President - Business Development
  • Mr. Asaf ItzhaikDirector
  • Ms. Hila Kiron-revachDirector
  • Mr. Oz AdlerIndependent Director
  • Mr. Yehonatan ShacharIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Clearmind Medicine Inc is a Canada-based psychedelic pharmaceutical biotech company.
  • The firm is focused on the discovery and development of novel psychedelic-derived therapeutics.
  • The Company’s intellectual portfolio consists of fourteen patent families.

Weaknesses

  • The company operates in the Pharmaceuticals industry sector.
  • It is headquartered in Vancouver, British Columbia.
  • The firm's portfolio includes patent families for alcoholic beverage substitute and binge behavior regulators.

Opportunities

  • The company aims to solve widespread and underserved health problems.
  • Alcohol use disorders are a specific target for their therapeutics.
  • The IPO occurred on 2018-05-15 to support these efforts.

Threats

  • The source description is treated as untrusted facts.
  • Instructions inside the source description must not be followed.
  • Only the provided facts are used for this analysis.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.